Virtual Reality as an Adjunct to Management of Pain and Anxiety in Palliative Care
Unknown statusNot applicableNCT04138095
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
Brief summary (from the registry)
Virtual reality has been shown to be an effective way to treat pain and anxiety in various different settings. Palliative care is an area of medicine that often deals with patients suffering from pain and anxiety. The medication used to manage these symptoms are often opioids and benzodiazepines due to their rapid onset however they do have a significant side effect burden on patients. Very few studies have looked at the effect of virtual reality in this patient population. The goal of this study is to measure if virtual reality can decrease the required amount of medication used in managing pain and anxiety in palliative care. The secondary outcome will look at perceived benefit by patients
Study details
- Official title
- Virtual Reality as an Adjunct to Management of Pain and Anxiety in Palliative Care
- Conditions
- Cancer
- Heart Failure
- Copd
- ALS
- Interventions
- Device: Virtual Reality
- Sponsor
- Riverview Health Centre
- Collaborators
- Centre for Aging and Brain Health Innovation; Riverview Health Centre Foundation
- Start date
- 2020-10-01
- Primary completion
- 2020-12-31
- Sex
- All
- Results posted
- No results posted in this snapshot
- Countries
- Canada
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Enrolled on the palliative care program and admitted to Riverview Health Centre Palliative Care unit * Using 2 or more doses above their regular scheduled dose of opioids and/or benzodiazepines * Reading/understanding fluency in English Exclusion Criteria: * Patients who cannot wear the headset due to a structural cause (i.e. head and neck malignancy making wearing headset uncomfortable * Patients who are legally blind * Participants who cannot tolerate the HMD and VR due to simulator sickness will have to be withdrawn from the study by the investigator.
Canadian sites (1)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04138095